HK1167662A1 - Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids - Google Patents
Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aidsInfo
- Publication number
- HK1167662A1 HK1167662A1 HK12108236.3A HK12108236A HK1167662A1 HK 1167662 A1 HK1167662 A1 HK 1167662A1 HK 12108236 A HK12108236 A HK 12108236A HK 1167662 A1 HK1167662 A1 HK 1167662A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aids
- microparticles
- secretion
- inhibiting
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21347109P | 2009-06-12 | 2009-06-12 | |
US12/783,829 US8431530B2 (en) | 2009-06-12 | 2010-05-20 | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
PCT/US2010/035698 WO2010144231A2 (en) | 2009-06-12 | 2010-05-21 | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1167662A1 true HK1167662A1 (en) | 2012-12-07 |
Family
ID=43306940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12108236.3A HK1167662A1 (en) | 2009-06-12 | 2012-08-22 | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids |
Country Status (7)
Country | Link |
---|---|
US (5) | US8431530B2 (xx) |
EP (1) | EP2440570B1 (xx) |
JP (1) | JP2012529293A (xx) |
CN (1) | CN102482325B (xx) |
CA (1) | CA2761121A1 (xx) |
HK (1) | HK1167662A1 (xx) |
WO (1) | WO2010144231A2 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8669226B2 (en) * | 2011-10-07 | 2014-03-11 | Morehouse School Of Medicine | Antimicrobial compositions and methods of use thereof |
WO2013052058A1 (en) * | 2011-10-07 | 2013-04-11 | Morehouse School Of Medicine | Antimicrobial compositions and methods of use thereof |
US12083158B2 (en) | 2011-10-07 | 2024-09-10 | Morehouse School Of Medicine | Antibacterial compositions, methods of making and use thereof |
WO2013090556A1 (en) * | 2011-12-13 | 2013-06-20 | The Ohio State University | Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis |
US10702581B2 (en) | 2015-05-04 | 2020-07-07 | Ilias Biologics Inc. | Compositions containing protein loaded exosome and methods for preparing and delivering the same |
EP3356522A4 (en) * | 2016-09-30 | 2019-03-27 | Cellex Life Sciences, Incorporated | PROTEIN-PROTECTED EXOSOME-CONTAINING COMPOSITIONS AND METHODS FOR PREPARING AND ADMINISTERING SAME |
US10800817B2 (en) | 2016-12-19 | 2020-10-13 | Morehouse School Of Medicine | Compositions and methods for treating diseases by inhibiting exosome release |
WO2018118015A1 (en) * | 2016-12-19 | 2018-06-28 | Morehouse School Of Medicine | Compositions and methods for treating diseases by inhibiting exosome release |
EP3630180A1 (en) | 2017-06-01 | 2020-04-08 | Compugen Ltd. | Triple combination antibody therapies |
WO2020081634A2 (en) * | 2018-10-16 | 2020-04-23 | George Mason Research Foundation, Inc. | Compositions and methods for modulation of extracellular vesicle release and treatment of neurological disorders |
US11180534B1 (en) | 2021-06-04 | 2021-11-23 | Morehouse School Of Medicine | Compositions and methods for treating SARS-CoV-2 infections |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
FR2771640B1 (fr) * | 1997-12-03 | 2000-02-11 | Inst Nat Sante Rech Med | Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques |
US6551795B1 (en) * | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
EP1455816A4 (en) * | 2000-10-19 | 2007-03-28 | Epimmune Inc | HLA CLASS I AND II BINDING PEPTIDES AND THEIR USE |
US20030229906A1 (en) * | 2002-04-15 | 2003-12-11 | Gelman Irwin H. | Methods and compositions for the treatment of disorders of HIV infection |
EP1605972A2 (en) * | 2003-03-26 | 2005-12-21 | Cytos Biotechnology AG | Hiv-peptide-carrier-conjugates |
-
2010
- 2010-05-20 US US12/783,829 patent/US8431530B2/en active Active
- 2010-05-21 CA CA2761121A patent/CA2761121A1/en not_active Abandoned
- 2010-05-21 WO PCT/US2010/035698 patent/WO2010144231A2/en active Application Filing
- 2010-05-21 EP EP10786562.8A patent/EP2440570B1/en not_active Not-in-force
- 2010-05-21 JP JP2012514976A patent/JP2012529293A/ja not_active Ceased
- 2010-05-21 CN CN201080025184.7A patent/CN102482325B/zh active Active
-
2012
- 2012-08-22 HK HK12108236.3A patent/HK1167662A1/xx unknown
- 2012-09-17 US US13/621,618 patent/US8476237B2/en active Active
- 2012-09-17 US US13/621,597 patent/US8551943B2/en active Active
- 2012-12-04 US US13/693,507 patent/US8563506B2/en active Active
-
2013
- 2013-08-30 US US14/015,438 patent/US8871708B2/en active Active - Reinstated
Also Published As
Publication number | Publication date |
---|---|
JP2012529293A (ja) | 2012-11-22 |
EP2440570B1 (en) | 2013-08-14 |
US20130123202A1 (en) | 2013-05-16 |
US20140005117A1 (en) | 2014-01-02 |
US8563506B2 (en) | 2013-10-22 |
EP2440570A4 (en) | 2012-04-18 |
WO2010144231A3 (en) | 2011-04-21 |
US20130018002A1 (en) | 2013-01-17 |
WO2010144231A2 (en) | 2010-12-16 |
CN102482325A (zh) | 2012-05-30 |
US20140121170A2 (en) | 2014-05-01 |
CA2761121A1 (en) | 2010-12-16 |
CN102482325B (zh) | 2015-01-07 |
US8871708B2 (en) | 2014-10-28 |
US8431530B2 (en) | 2013-04-30 |
US8476237B2 (en) | 2013-07-02 |
EP2440570A2 (en) | 2012-04-18 |
US20130018003A1 (en) | 2013-01-17 |
US8551943B2 (en) | 2013-10-08 |
US20100317566A1 (en) | 2010-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267342A (en) | Antibodies and preparations containing them for the treatment of cancer | |
HK1167662A1 (en) | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles aids | |
IL225471A0 (en) | Preparations and methods for the prevention and treatment of cancer | |
HK1217900A1 (zh) | 用於預防或治療眼科病症的方法和組合物 | |
EP2473054A4 (en) | COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA | |
IL218987A0 (en) | Methods and compositions for treating cancer | |
EP2361089A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE | |
IL251083B (en) | Compounds and preparations for the treatment of cancer | |
HK1159498A1 (en) | Methods and compositions for the treatment of cancer | |
EP2558085A4 (en) | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER | |
HK1166305A1 (zh) | 用於治療炎症的組合物及方法 | |
EP2504428A4 (en) | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING | |
EP2419136A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
EP2340027A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP2429584A4 (en) | TREATMENT PROCEDURE AND COMPOSITIONS | |
ZA201106577B (en) | Compounds and compositions for cognition-enhancement,methods of making,and methods of treating | |
EP2437738A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
EP2635273A4 (en) | ISOFLAVONOID COMPOSITIONS AND METHOD FOR CANCER TREATMENT | |
EP2391211A4 (en) | METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER | |
GB0917745D0 (en) | Compositions for the prevention or treatment of migraine | |
EP2411031A4 (en) | Methods and compositions for the treatment of cancer | |
EP2547368A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
EP2608794A4 (en) | METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBESITY | |
EP2480099A4 (en) | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES |